lectures 7 & 8 chemotherapy of bacterial infections
TRANSCRIPT
![Page 1: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/1.jpg)
![Page 2: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/2.jpg)
Chemotherapy of Bacterial Infections
~~~~~~~~Antibiotics
![Page 3: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/3.jpg)
Definitions of Antibiotics• OLD: An antibiotic is a chemical
substance produced by various species of microorganisms that is capable in small concentrations of inhibiting the growth of other microorganisms
• NEW: An antibiotic is a product produced by a microorganism or a similar substance produced wholly or partially by chemical synthesis, which in low concentrations, inhibits the growth of other microorganisms
![Page 4: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/4.jpg)
Impact of Modern Healthcare on Life Expectancy
![Page 5: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/5.jpg)
HistoryPaul Ehrlich
“Magic Bullet” Chemicals with selective toxicity
ORIGIN: Selective StainsDRUG:Arsphenamine (1910)
“606” Salvarsan
NOBEL: 1908
![Page 6: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/6.jpg)
History(cont’d)
Gerhard Domagk Drugs are changed in the body
ORIGIN: Prontosil(Only active in vivo)
DRUG: Sulfanilamide (1935)
NOBEL: 1939
![Page 7: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/7.jpg)
History
Alexander Fleming Microbes make antibiotics
ORIGIN: moldy culture plateDRUG: Penicillin (1928)
NOBEL: 1945
(cont’d)
![Page 8: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/8.jpg)
History(cont’d)
Selman Waksman Soil Streptomyces make antibiotics comes up with definition of antibiotic
ORIGIN: Penicillin developmentDRUG:Streptomycin (1943)
NOBEL: 1952
![Page 9: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/9.jpg)
The Ideal Drug*1. Selective toxicity: against target pathogen but not against host
LD50 (high) vs. MIC and/or MBC (low)
2. Bactericidal vs. bacteriostatic3. Favorable pharmacokinetics: reach target site in body with
effective concentration
4. Spectrum of activity: broad vs. narrow
5. Lack of “side effects” Therapeutic index: effective to toxic dose ratio
6. Little resistance development
* There is no perfect drug.
![Page 10: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/10.jpg)
![Page 11: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/11.jpg)
Antibacterial spectrum—Range of activityof an antimicrobial against bacteria. Abroad-spectrum antibacterial drug caninhibit a wide variety of gram-positive andgram-negative bacteria, whereas anarrow-spectrum drug is active onlyagainst a limited variety of bacteria.
Bacteriostatic activity—-The level ofantimicro-bial activity that inhibits thegrowth of an organism. This is determinedin vitro by testing a standardizedconcentration of organisms against aseries of antimicrobial dilutions. Thelowest concentration that inhibits thegrowth of the organism is referred to asthe minimum inhibitory concentration(MIC).
Bactericidal activity—The level ofantimicrobial activity that kills the testorganism. This is determined in vitro byexposing a standardized concentration oforganisms to a series of antimicrobialdilutions. The lowest concentration thatkills 99.9% of the population is referred toas the minimum bactericidalconcentration (MBC).
Antibiotic combinations—Combinations ofantibiotics that may be used (1) to broadenthe antibacterial spectrum for empirictherapy or the treatment of polymicrobialinfections, (2) to prevent the emergence ofresistant organisms during therapy, and (3)to achieve a synergistic killing effect.
Antibiotic synergism—Combinations oftwo antibiotics that have enhancedbactericidal activity when tested togethercompared with the activity of eachantibiotic.
Antibiotic antagonism—Combination ofantibiotics in which the activity of oneantibiotic interferes With the activity of theother (e.g., the sum of the activity is lessthan the activity of the individual drugs).
Beta-lactamase—An enzyme thathydrolyzes the beta-lactam ring in thebeta-lactam class of antibiotics, thusinactivating the antibiotic. The enzymesspecific for penicillins and cephalosporinsaret he penicillinases andcephalosporinases, respectively.
![Page 12: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/12.jpg)
Susceptibility Tests1. Broth dilution - MIC test
2. Agar dilution - MIC test
![Page 13: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/13.jpg)
32 ug/ml 16 ug/ml 8 ug/ml 4 ug/ml 2 ug/ml 1 ug/ml
Sub-culture to agar medium MIC = 8 ug/mlMBC = 16 ug/ml
Minimal Inhibitory Concentration (MIC)vs.
Minimal Bactericidal Concentration (MBC)
![Page 14: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/14.jpg)
Susceptibility Tests
3. Agar diffusion Kirby-Bauer Disk Diffusion Test
(cont’d)
![Page 15: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/15.jpg)
Susceptibility Tests“Kirby-Bauer Disk-plate test”
Diffusion depends upon:1. Concentration2. Molecular weight3. Water solubility4. pH and ionization5. Binding to agar
(cont’d)
![Page 16: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/16.jpg)
Susceptibility Tests“Kirby-Bauer Disk-plate test”
Zones of Inhibition (~ antimicrobial activity) depend upon:
1. pH of environment2. Media components
Agar depth, nutrients3. Stability of drug4. Size of inoculum5. Length of incubation6. Metabolic activity of organisms
(cont’d)
![Page 17: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/17.jpg)
Antibiotic Mechanisms of Action
Transcription
Translation
Translation
Alteration of Cell Membrane Polymyxins Bacitracin Neomycin
![Page 18: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/18.jpg)
Mechanism of Action
1. ANTIMETABOLITE ACTION Sulfonamides
an analog of PABA, works by competitive inhibition
Trimethoprim-sulfamethoxazole a synergistic combination; useful against
UTIs
![Page 19: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/19.jpg)
Mechanism of Action ANTIMETABOLITE ACTION
(cont’d)
tetrahydrofolic acid
![Page 20: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/20.jpg)
Mechanism of Action
2. ALTERATION OF CELL MEMBRANES Polymyxins and colistin
destroys membranes active against gram negative bacilli serious side effects used mostly for skin & eye infections
(cont’d)
![Page 21: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/21.jpg)
Mechanism of Action ALTERATION OF CELL MEMBRANES
(cont’d)
![Page 22: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/22.jpg)
Mechanism of Action3. INHIBITION OF PROTEIN SYNTHESIS:
Steps in synthesis:1. Initiation2. Elongation3. Translocation4. Termination
(cont’d)
• Prokaryotes and eukaryotes (80S) have a different structure to ribosomes so can use antibiotics for selective toxicity against ribosomes of prokaryotes (70S)
![Page 23: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/23.jpg)
Mechanism of ActionINHIBITION OF PROTEIN SYNTHESIS (cont’d)
• Aminoglycosides bind to bacterial ribosome on 30S subunit;
and blocks formation of initiation complex. Both actions lead to mis-incorporation of amino acids
Examples:Gentamicin TobramycinAmikacin StreptomycinKanamycin SpectinomycinNeomycin
![Page 24: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/24.jpg)
Mechanism of ActionINHIBITION OF PROTEIN SYNTHESIS
(cont’d)
• Aminoglycosides (cont’d)
broad spectrum• Gram negative rods• P. aeruginosa• Drug-resistant gram negative rods• Plague, Tularemia, Gonorrhea• Pre-op (bowel)• External (skin)
toxic at some level to eighth cranial nerve
![Page 25: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/25.jpg)
Mechanism of ActionINHIBITION OF PROTEIN SYNTHESIS
(cont’d)
• Macrolides: chloramphenicol & erythromycin bind to 50S subunit and blocks the
translocation step
Mycoplasma
Legionella
S. pyogenes
Chloramphenicol: broad spectrum
Erythromycin:
Anaerobes
Typhoid
Meningitis
![Page 26: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/26.jpg)
Mechanism of ActionINHIBITION OF PROTEIN SYNTHESIS
(cont’d)
• Clindamycin binds to 50S subunit and interferes with
binding of the amino acid – acyl-tRNA complex and so inhibits peptidyl transferase
works best against• Staphylococcus• Bacteroides & anaerobic gram neg rods
Penicillin allergic people
![Page 27: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/27.jpg)
• Tetracyclines bind to 30S subunit and interferes with
the attachment of the tRNA carrying amino acids to the ribosome
effective against:• Chlamydia• Rickettsia• Mycoplasma• Brucella
Mechanism of ActionINHIBITION OF PROTEIN SYNTHESIS
(cont’d)
![Page 28: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/28.jpg)
Mechanism of Action
4. INHIBITION OF DNA/RNA SYNTHESIS Rifampin
binds to RNA polymerase active against gram positive cocci bactericidal for Mycobacterium used for treatment and prevention of
meningococcus
(cont’d)
![Page 29: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/29.jpg)
Mechanism of Action INHIBITION OF DNA/RNA SYNTHESIS
Metronidazole breaks down into intermediate that
causes breakage of DNA active against:
– protozoan infections– anaerobic gram negative infections
(cont’d)
Quinolones and fluoroquinolones effect DNA gyrase broad spectrum
![Page 30: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/30.jpg)
(cont’d)
Mechanism of Action INHIBITION OF DNA/RNA SYNTHESIS
![Page 31: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/31.jpg)
Mechanism of Action5. CELL WALL SYNTHESIS INHIBITORS
Steps in synthesis:1. NAM-peptide made in cytoplasm2. attached to bactoprenol in cell membrane3. NAG is added4. whole piece is added to growing cell wall5. crosslinks added
• the β-Lactams• the non β-Lactams
(cont’d)
![Page 32: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/32.jpg)
![Page 33: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/33.jpg)
Mechanism of Action5. CELL WALL SYNTHESIS INHIBITORS
β-Lactam Antibiotics Penicillins Cephalosporins Carbapenems Monobactams
(cont’d)
![Page 34: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/34.jpg)
Mechanism of ActionCELL WALL SYNTHESIS INHIBITORS
β-Lactam ring structure
(cont’d)
![Page 35: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/35.jpg)
![Page 36: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/36.jpg)
Mechanism of ActionCELL WALL SYNTHESIS INHIBITORS
Action of β-Lactam antibiotics
(cont’d)
1. Bactericidal; growing cells only
2. Drug links covalently to regulatory enzymes called PBPs (penicillin-binding proteins)
3. Blocks cross-linkage of peptidoglycan
![Page 37: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/37.jpg)
Mechanism of ActionCELL WALL SYNTHESIS INHIBITORS
Action of β-Lactam antibiotics(cont’d)
For E. coli> MIC
wall damage autolysins spheroplasting cell lysis
< MIC no septa filaments
![Page 38: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/38.jpg)
![Page 39: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/39.jpg)
Resistance to β-Lactams – Gram pos.
Mechanism of ActionCELL WALL SYNTHESIS INHIBITORS
(cont’d)
![Page 40: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/40.jpg)
Resistance to β-Lactams – Gram neg.
Mechanism of ActionCELL WALL SYNTHESIS INHIBITORS
(cont’d)
![Page 41: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/41.jpg)
Non - β-Lactams
Mechanism of ActionCELL WALL SYNTHESIS INHIBITORS
(cont’d)
Vancomycinactive against gram positive cocci, but not gram negative because too large to pass through outer membrane interferes with PG elongation
Cycloserine, ethionamide and isoniazidinhibits enzymes that catalyze cell wall synthesisfor Mycobacterial infections
![Page 42: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/42.jpg)
Clinical UsesPATHOGENS TYPICAL DRUG
Gram positivePen-ase (-)Pen-ase (+)
Penicillin G (oral or IM)Methicillin, Nafcillin
Gram negativeEnterics, etc.
PseudomonasB. fragilis
Ampicillin, gentamicin, etc.Ticarcillin, tobramycin
Clindamycin
![Page 43: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/43.jpg)
Clinical Uses(cont’d)
PATHOGENS TYPICAL DRUGMycobacterium Streptomycin
Iso-nicotinic hydrazide (INH)Fungi:
CutaneousDeep
NystatinAmphotericin B, ketoconazol
Parasites:Plasmodium
GiardiaChloroquineQuinacrine
![Page 44: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/44.jpg)
Resistance Physiological Mechanisms
1. Lack of entry – tet, fosfomycin2. Greater exit
efflux pumps tet (R factors)
3. Enzymatic inactivation bla (penase) – hydrolysis CAT – chloramphenicol acetyl transferase Aminogylcosides & transferases
![Page 45: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/45.jpg)
Resistance Physiological Mechanisms
4. Altered target RIF – altered RNA polymerase (mutants) NAL – altered DNA gyrase STR – altered ribosomal proteins ERY – methylation of 23S rRNA
5. Synthesis of resistant pathway TMPr plasmid has gene for DHF reductase;
insensitive to TMP
(cont’d)
![Page 46: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/46.jpg)
Origin of Drug Resistance
• Non-genetic metabolic inactivity
• Mycobacteria non-genetic loss of target
• penicillin – non-growing cells, L-forms intrinsic resistance
• some species naturally insensitive
![Page 47: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/47.jpg)
Origin of Drug Resistance
• Genetic spontaneous mutation of old genes
• Vertical evolution Acquisition of new genes
• Horizontal evolution
• Chromosomal Resistance• Extrachromosomal Resistance
• Plasmids, Transposons, Integrons
(cont’d)
![Page 48: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/48.jpg)
Plasmids• independent replicons
circular DNA• dispensable• several genes
drug resistance metabolic enzymes virulence factors
• host range restricted or broad
![Page 49: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/49.jpg)
Plasmids• size
small, non-conjugal large, conjugal <25 kbp
• Transfer between cells: CONJUGATION (cell to cell contact)
• due to plasmid tra genes (for pili, etc) NON-CONJUGAL
• transduction • mobilization by conjugation plasmids
(cont’d)
![Page 50: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/50.jpg)
Implicationsof Resistance
• Household agents they inhibit bacterial growth purpose is to prevent transmission of
disease-causing microbes to noninfected persons.
can select for resistant strains• NO evidence that they are useful in a
healthy household
![Page 51: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/51.jpg)
Implications of Resistance• Triclosan studies
effect diluted by water one gene mutation for resistance contact time exceeds normal handwash time (5
seconds)• Allergies
link between too much hygiene and increased allergy frequency
• http://www.healthsci.tufts.edu/apua/ROAR/roarhome.htm
![Page 52: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/52.jpg)
Implicationsof Resistance
• www.roar.apua.org
![Page 53: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/53.jpg)
![Page 54: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/54.jpg)
REVIEW
![Page 55: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/55.jpg)
32 ug/ml 16 ug/ml 8 ug/ml 4 ug/ml 2 ug/ml 1 ug/ml
Sub-culture to agar medium MIC = 8 ug/mlMBC = 16 ug/ml
Minimal Inhibitory Concentration (MIC)vs.
Minimal Bactericidal Concentration (MBC)
REVIEW
![Page 56: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/56.jpg)
What are main targets of Antibiotics?
REVIEW
![Page 57: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/57.jpg)
Mechanism of Action
INHIBITION OF CELL WALL SYNTHESIS• β-Lactams• Non β-Lactams
REVIEW
![Page 58: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/58.jpg)
Mechanism of ActionCELL WALL SYNTHESIS INHIBITORS
β-Lactam ring structure
(cont’d)
REVIEW
![Page 59: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/59.jpg)
Mechanism of Action
• Aminoglycosides• Macrolides
ChloramphenicolErythromycin
• Tetracyclines• Clindamycin
INHIBITION OF PROTEIN SYNTHESIS
REVIEW
![Page 60: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/60.jpg)
Mechanism of Action
INHIBITION OF NUCLEIC ACID SYNTHESIS Rifampin Metronidazole Quinolones and fluoroquinolones
REVIEW
![Page 61: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/61.jpg)
Mechanism of Action
DISRUPTION OF CELL MEMBRANES Polymyxins Colistin
REVIEW
![Page 62: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/62.jpg)
Mechanism of Action
ANTIMETABOLITE ACTION Sulfonamides Trimethoprim-sulfamethoxazole
REVIEW
![Page 63: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/63.jpg)
Resistance Physiological Mechanisms
1. Lack of entry – tet, fosfomycin2. Greater exit
efflux pumps tet (R factors)
3. Enzymatic inactivation bla (penase) – hydrolysis CAT – chloramphenicol acetyl transferase Aminogylcosides & transferases
REVIEW
![Page 64: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/64.jpg)
Resistance Physiological Mechanisms
4. Altered target RIF – altered RNA polymerase (mutants) NAL – altered DNA gyrase STR – altered ribosomal proteins ERY – methylation of 23S rRNA
5. Synthesis of resistant pathway TMPr plasmid has gene for DHF reductase;
insensitive to TMP
(cont’d)
REVIEW
![Page 65: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/65.jpg)
Resistance to β-Lactams – Gram pos.
Mechanism of ActionCELL WALL SYNTHESIS INHIBITORS
(cont’d)
REVIEW
![Page 66: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/66.jpg)
Resistance to β-Lactams – Gram neg.
Mechanism of ActionCELL WALL SYNTHESIS INHIBITORS
(cont’d)
REVIEW
![Page 67: Lectures 7 & 8 Chemotherapy of Bacterial Infections](https://reader031.vdocuments.us/reader031/viewer/2022021500/589da5c71a28aba44a8bd92a/html5/thumbnails/67.jpg)